Ikena Oncology, Inc.
IKNA
$1.14
-$0.01-0.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M |
| Total Depreciation and Amortization | 87.00K | 89.00K | 90.00K | 92.00K | 219.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.24M | 1.24M | 1.27M | 1.32M | 2.89M |
| Change in Net Operating Assets | -3.27M | 1.54M | -64.00K | -181.00K | -5.27M |
| Cash from Operations | -10.56M | -6.26M | -8.94M | -12.50M | -18.30M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 190.00K | 185.00K | 60.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.93M | 463.00K | 9.26M | 3.73M | -48.80M |
| Cash from Investing | 7.93M | 463.00K | 9.45M | 3.92M | -48.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.63M | -5.80M | 516.00K | -8.58M | -67.04M |